# First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

> **NCT06657222** · PHASE1,PHASE2 · RECRUITING · sponsor: **Tubulis GmbH** · enrollment: 250 (estimated)

## Conditions studied

- Advanced Solid Tumors
- HNSCC
- SCLC
- NSCLC
- TNBC - Triple-Negative Breast Cancer
- CRC

## Interventions

- **DRUG:** TUB-030

## Key facts

- **NCT ID:** NCT06657222
- **Lead sponsor:** Tubulis GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-13
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06657222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06657222, "First in Human Study of TUB-030 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06657222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*